Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,681 | 725 | 99.4% |
| Education | $66.32 | 7 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $972.52 | 62 | $0 (2024) |
| PFIZER INC. | $897.81 | 66 | $0 (2024) |
| ABBVIE INC. | $834.52 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $798.88 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $767.92 | 42 | $0 (2024) |
| Novo Nordisk Inc | $738.65 | 57 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $495.91 | 40 | $0 (2023) |
| Lilly USA, LLC | $476.56 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $417.93 | 31 | $0 (2023) |
| Abbott Laboratories | $378.47 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $815.67 | 40 | AstraZeneca Pharmaceuticals LP ($219.09) |
| 2023 | $1,703 | 106 | PFIZER INC. ($320.07) |
| 2022 | $1,697 | 104 | Amgen Inc. ($281.54) |
| 2021 | $1,860 | 115 | Biohaven Pharmaceuticals, Inc. ($331.26) |
| 2020 | $711.79 | 46 | Allergan, Inc. ($139.17) |
| 2019 | $1,220 | 79 | AstraZeneca Pharmaceuticals LP ($244.32) |
| 2018 | $1,314 | 107 | GlaxoSmithKline, LLC. ($216.19) |
| 2017 | $1,426 | 135 | GlaxoSmithKline, LLC. ($255.37) |
All Payment Transactions
732 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Obesity | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.56 | General |
| 08/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes Care | ||||||
| 03/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Diabetes Care | ||||||
| 03/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.26 | General |
| 03/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 791 | 1,558 | $200,398 | $55,267 |
| 2022 | 11 | 656 | 1,596 | $174,313 | $46,567 |
| 2021 | 12 | 742 | 1,603 | $175,481 | $60,232 |
| 2020 | 10 | 760 | 1,534 | $136,971 | $55,833 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 588 | $115,248 | $26,082 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 229 | $31,831 | $9,068 | 28.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,985 | $5,365 | 89.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 174 | 400 | $4,112 | $3,160 | 76.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $3,192 | $3,011 | 94.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 51 | 51 | $17,901 | $2,879 | 16.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $12,604 | $1,839 | 14.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 51 | $1,887 | $1,419 | 75.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,825 | $1,259 | 32.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $703.00 | $528.77 | 75.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 26 | $1,534 | $201.60 | 13.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 11 | $803.00 | $199.56 | 24.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 27 | 47 | $423.00 | $143.06 | 33.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 14 | $350.00 | $110.54 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 633 | $124,068 | $29,634 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 241 | $33,356 | $10,183 | 30.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $2,046 | $1,847 | 90.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,834 | $1,698 | 35.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 186 | 433 | $3,031 | $1,268 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,369 | $973.44 | 71.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 71 | $4,189 | $597.52 | 14.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 12 | $821.00 | $237.38 | 28.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 16 | 31 | $279.00 | $97.07 | 34.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 44 | $176.00 | $28.63 | 16.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 48 | $144.00 | $3.03 | 2.1% |
About Dr. Michael Beard, MD
Dr. Michael Beard, MD is a Family Medicine healthcare provider based in Benton, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316949167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Beard, MD has received a total of $10,748 in payments from pharmaceutical and medical device companies, with $815.67 received in 2024. These payments were reported across 732 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,681).
As a Medicare-enrolled provider, Beard has provided services to 2,949 Medicare beneficiaries, totaling 6,291 services with total Medicare billing of $217,899. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Benton, AR
- Active Since 08/11/2005
- Last Updated 03/13/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316949167
Products in Payments
- NURTEC ODT (Drug) $637.69
- Aimovig (Biological) $616.07
- VRAYLAR (Drug) $605.31
- FARXIGA (Drug) $514.01
- TROKENDI XR (Drug) $409.27
- Vascepa (Drug) $327.87
- TRELEGY ELLIPTA (Drug) $326.33
- REXULTI (Drug) $273.81
- Ozempic (Drug) $269.18
- JANUVIA (Drug) $241.55
- Synthroid (Drug) $240.72
- TRINTELLIX (Drug) $238.95
- EMGALITY (Drug) $223.29
- ENTRESTO (Drug) $220.92
- ELIQUIS (Drug) $194.95
- Otezla (Drug) $190.75
- UBRELVY (Drug) $187.60
- XIFAXAN (Drug) $185.57
- FREESTYLE LIBRE 3 (Device) $176.59
- BREO (Drug) $172.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Benton
Dr. Mark Albey, M.d, M.D
Family Medicine — Payments: $13,713
Dr. James Cooper, M.d, M.D
Family Medicine — Payments: $11,906
Joseph Morgan, D.o, D.O
Family Medicine — Payments: $11,767
Dr. Richard Rethorst, Md, MD
Family Medicine — Payments: $11,275
Dr. Evelyn Cathcart, M.d, M.D
Family Medicine — Payments: $10,641
Dr. Kirk Watson, M.d, M.D
Family Medicine — Payments: $9,079